Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone injection for birch pollen induced allergic rhinitis
2018-004205-12Phase 4Completed
- Sponsor
- Region Skåne
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylprednisolone in allergic rhinitis (AR) (3 arms), sponsored by Region Skåne. Primary endpoint: Daily symptom score difference. Started Dec 2018; status: completed.
02
Drugs
methylprednisolone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2018-004205-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004205-12.